ArticleInternational journal of molecular sciences2024

A Novel Glycoengineered Humanized Antibody Targeting DLK1 Exhibits Potent Anti-Tumor Activity in DLK1-Expressing Liver Cancer Cell Xenograft Models.

Koji Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.